A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial

PURPOSE: The purpose of this analysis of patient-reported outcomes from the ELECT (Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment) trial (NCT00774930) was to explore the effect of lanreotide on symptoms of carcinoid syndrome. Specifically, this post hoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Blot, Koenraad, Duchateau, Luc, Lescrauwaet, Benedicte, Liyanage, Nilani, Ray, David, Mirakhur, Beloo, Vinik, Aaron I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825468/
https://www.ncbi.nlm.nih.gov/pubmed/31754316
http://dx.doi.org/10.2147/PROM.S219982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825468/
https://www.ncbi.nlm.nih.gov/pubmed/31754316
http://dx.doi.org/10.2147/PROM.S219982

Ejemplares similares